Hong Kong
· Delayed Price · Currency is HKD CanSino Biologics Statistics
Total Valuation
HKG:6185 has a market cap or net worth of HKD 12.60 billion. The enterprise value is 11.35 billion.
| Market Cap | 12.60B |
| Enterprise Value | 11.35B |
Important Dates
The next estimated earnings date is Wednesday, March 26, 2025.
| Earnings Date | Mar 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6185 has 247.04 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 247.04M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 28.92% |
| Owned by Institutions (%) | 9.44% |
| Float | 168.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.02 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.14 |
| EV / Sales | 12.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.32% and return on invested capital (ROIC) is -3.10%.
| Return on Equity (ROE) | -7.32% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -3.10% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 602,844 |
| Profits Per Employee | -269,878 |
| Employee Count | 1,494 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +103.18% in the last 52 weeks. The beta is 0.68, so HKG:6185's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +103.18% |
| 50-Day Moving Average | 31.04 |
| 200-Day Moving Average | 24.99 |
| Relative Strength Index (RSI) | 58.57 |
| Average Volume (20 Days) | 1,979,568 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6185 had revenue of HKD 900.65 million and -403.20 million in losses. Loss per share was -1.63.
| Revenue | 900.65M |
| Gross Profit | 900.65M |
| Operating Income | -399.30M |
| Pretax Income | -405.67M |
| Net Income | -403.20M |
| EBITDA | -143.49M |
| EBIT | -399.30M |
| Loss Per Share | -1.63 |
Balance Sheet
The company has 3.49 billion in cash and 2.24 billion in debt, giving a net cash position of 1.26 billion or 5.09 per share.
| Cash & Cash Equivalents | 3.49B |
| Total Debt | 2.24B |
| Net Cash | 1.26B |
| Net Cash Per Share | 5.09 |
| Equity (Book Value) | 5.39B |
| Book Value Per Share | 21.90 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -44.33% and -44.77%.
| Gross Margin | 100.00% |
| Operating Margin | -44.33% |
| Pretax Margin | -45.04% |
| Profit Margin | -44.77% |
| EBITDA Margin | -15.93% |
| EBIT Margin | -44.33% |
| FCF Margin | n/a |
Dividends & Yields
HKG:6185 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | -3.20% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |